Nathan Bachtell

Biography

Dr. Bachtell joined Symic Bio in March of 2014 and will be leading clinical research and medical affairs initiatives. Previously, he was the medical as well as global team lead in the osteoarthritis (OA) development program at Genzyme (now part of Sanofi) where he focused on symptomatic and disease modification therapies. During his time in industry Dr. Bachtell worked on biologics, cell therapies as well as medical devices, and led teams in pharmacovigilance, clinical research and medical affairs. His therapeutic focus included general orthopedics, dermatology, immune mediated diseases, and neurology. Prior to industry, he was an attending physician at a teaching hospital as well as an advisor and principal investigator for a biotechnology start up. Dr. Bachtell received his MD from UC San Francisco, completed residency at Oregon Health Sciences University and earned a Masters in Management from Harvard University.

Research Interest

clinical research and medical affairs